Rbg Dividends - RBGP

Rbg Dividends - RBGP

Trade Now

Capital at risk Advertisement
Stock Name Stock Symbol Market Stock Type
Rbg Holdings Plc RBGP London Ordinary Share
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 87.50 01:00:00
Open Price Low Price High Price Close Price Previous Close
87.50 87.50 87.50 87.50
more quote information »
Industry Sector

Rbg RBGP Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount

Top Dividend Posts

Top Posts
Posted at 14/9/2022 08:11 by maddox
Simon Thompson of Chronic Investor tips RBGP as BUY to take advantage of 45% price anomaly to peers. No share price target is stated but doing the math and it would be 157p. ST's investment case is laid out in much more detail in this report from Progressive Research httPS://progressive-research.com/wp-content/uploads/data-sync/research/RBGP%2020220719.pdf
Posted at 18/7/2022 09:25 by maddox
Great to see in today's trading update that despite the depressed stock market RBGP is trading well and in-line with market expectations. I'm particularly pleased to see that 'market expectations' is referenced and stated: This adds absolute clarity and I wish more firms would follow this best practice. The integration of MC appears to be going well and the EBITDA margin improvements are very positive. The other Divisions are trading strongly which is reassuring with the general poor economic sentiment. A key attraction for me is that the Legal Services market tends overall to be uncorrelated with the general economy. If one part of the market is suffering another tends to be busy. The degree to which this true and recognised by Mr Market we'll have to wait and see - Legal Services as an investible sector is still relatively recent.
Posted at 13/6/2022 18:25 by goldbutler
There is an article ' pitted against the Best' from many years ago in Independent and it deals with Brands Hatch which was sold BY yes the dealmaker Ceo. The background is wonderful and John Webb and his wife are mentioned in the article all around Brands Hatch . the company was sold and it had approx 1050 acres of land but the article shows that all those KPIS and financial reporting it never moved the profits for 5 years. There are those who believe that it was the development potential of the land which helped the sale. But John also gave a very lengthy interview on the magazine MOTORSPORT 2011 which can be read online . wonderful interview about 1940 50s 60s days of the motor racing - But it is worth staying until the last section when he deals with the current CEO of RBGP , for she it was who took over brands hatch It raises the issue of the directors and staff from Brook Land onwards who have just got up and left. just what is the staff turnover like now at the legal firms when PQ solicitors working elsewhere are earning as much as the partners at rbgp or MC . Time for the current Ceo to say who the next CEO will be and chairman - because the shareprice is telling her and him that the game is up - the market is telling them enough GO now.
Posted at 13/6/2022 18:02 by goldbutler
Convex have announced a couple of deals recently but last year they had an exceptional year. so why did the dial on EPS NOT move , - one reason is that even with the Convex deals just finalising before year end , the CEO and CFO allocated themselves large bonus payments - and they did it t - 3quarters of a million Convex Rosenblatt and the 2nd legal outfit Memery Crystal have dumped their shares at the first opportunity. What are LOCK UP deals with partners for when they can avoid the agreement and trade hundreds of thousands of shares . no movement in the share price too. At least Mr driver and his team bought in the open market with their commission but they and partners in the MC outfit have dumped them - so why should private investors buy the shares -Where are the estimates for y/e 22 23 24 Well figures for y/e 24 show no growth in EPS from y/e 23 if you want a premium rating you need premium performance this CEO is out of her depth On one site RBGP estimates for y/e 22 have been adjusted downwards in the last two weeks. So where is the growth , where is the undervalue Is this Ceo & BOD going to claim Rbgp is an income share - there are plenty of better dividend shares out there with surplus cash and strong balance sheets Where is the EPS growth to come from - when the partners in the SBU's are selling out. And NO buying from the BOD. isnt it time the chairman was asked to leave. How can he sit at an AGM without one share to his name
Posted at 18/5/2022 16:07 by goldbutler
Leasing Liabilities appear in the y/e accounts @ £15,849,101 -inflation linked in many cases too. The buy of MC appears to have added £11,685,333 in addition to the Debt to make each of the partners there share out £30 million. So what will happen with any slowdown in the economy resulting in failure to meet revenue targets or profits. It doesn't read well Targets at Convex for deals and revenue and profits - are there any more deals. the incorrect strong pipeline figure given at the interim last year is poor financial reporting and it stinks - just how many times did the CEO or CFO speak with the leader at Convex between the beginning of the financial year and end of june. Mr Driver appears to have worked his socks off last year. But with costs last year of almost £5.2 million and deals announced to-date this can only result in a profit downgrade unless 'money for old rope' deals are finalised by end of next month. it doesn't read well Directors are of course in a sweet spot for buying the undervalued shares. The chairman he must be about to buy a share soon .How is he going to sit at the AGM without a share. The other Directors could buy a share for him and sing for he's a jolly goodfellow. The investments institutions and fund managers will/must be vicariously embarrassed for the CEO when she rolls up her sleeves, and gets proactive and tells them about all those reasons for buying the shares. such as the huge lease liabilities , large Bank loan and overdraft and a dividend that is effectively being paid out and cannot possibly be sustained with such lumpy revenues
Posted at 29/4/2022 15:29 by goldbutler
I note you haven't d/w other issues raised . MR brumby presentation 'SLAM' on rbgp was woeful , o level standard. is this the sum total of RBGP forecasts that they are reliant on mr thompson at investors chronicle. -
Posted at 29/4/2022 15:20 by goldbutler
well thanks for the hello Maddox #you give figures for y/e 22 but for y/e 23 est the peg is 1.1 on revenue of £60m and very little growth of 8% in eps. The company is headed by an individual clearly out of her depth shunned by institutional investors to the extent ( according to you and her ) that Ceo is going to go calling on them. what on earth do you think she will be asked? She will be asked what are the profit figures on the new lionfish and how will it transform cashflow profits PEG PE and eps. If it is to be transformational then she needs those figures for ye 23 ye 24 ye 25 into the market - now. If she thinks on 1x or 2x times money return and costs for insurance and others are taken out she needs to say that it can add 5p to 10p on eps. for her shareprice is heading below 100p. she needs to rule out any more acquisitions because her debt is all of revenue from rosenblatt and convex combined. The dividend is unsustainable going into economic slowdown. she is out of her depth. The BOD without a share between them are weak. #the accounts are full of red flags .corporate governance is weak.
Posted at 28/4/2022 16:40 by maddox
Hi goldbutler, Always good to see a new poster on the BB and indeed new to Advfn too. Jarvis Investment Management will be holding those 12% of RBGP shares as a Custodian (a.k.a. Nominee) on-behalf of very many personal investors with Trading, ISAs or SIPP accounts. So, they can't vote the shares in that role and thus don't have to declare a holding position in an RNS. The CEO Nichola Foulston does indeed believe that the shares are undervalued and I certainly wouldn't argue otherwise - Forward p/e 9.5, PEG 0.4 and a 6.28% yield. I don't think you need to see internal estimates of returns to come to that conclusion. The case investments are held close to cash invested - and that tends to be the preferred treatment by personal investors. She is seeking to encourage some more Financial Institutions to buy-in. This is probably the better means of driving a re-rating. In the meantime RBGP does present a good investment opportunity. I agree it would be good to have more access to Broker Research - however, Simon Thompson of Investors Chronicle has been very positive and his last stated share price target was 175p. Similarly Jack Brumby, Stockopedia's Analyst with a spt of 160p. House Broker Singers' research ain't for the likes of us unfortunately but Brokers Consensus spt is 157.5p. Are you considering investing? Regards Maddox
Posted at 28/4/2022 14:54 by goldbutler
i've just read an article in Mail from 2019. nearly 3 years ago corporate governance was raised and the article referred to options for CEO.Is this company not better off being run off market as the plaything of the CEO and CFO. there are some alarming items in the y/e results The lionfish put option exercisable against RBGP is something the Board should never have signed off. if there is to be a put option then it should be exercisable in the hands of RBGP not the minority interest in lionfish. The new IT company it would appear has a call option exercisable against RBGP , where rbgp is obliged to buy the company which it 40% owns within the next 6 years. on a multiple of profits .What multiple is being used? If there is to be a call option it should be in the hands of RBGP and the BOD should decide in 5 or 6 years whether or not they want to buy the IT company not the other way about. There seems to be a very big increase in the Bad debts , just what sort of due diligence was done with MC , what sort of clients with just no money to pay. MC does not advertise itself as doing work for non payers, or high street or off high st clients . Who or what are the non payers for legal work among their corporate or HNW clients. Last september 2021 she said that private research was to be done before the end of the year ,well its now nearly May and nothing . Are there any scenario Profit figures for new Lionfish money investment pot and the effects on EPS.
Posted at 27/1/2022 12:19 by se81
From singer this morning Today’s positive year end update prompts a 10% upgrade to our FY21 EBITDA forecast. RBG Legal Services is performing well under two highly regarded brands (Rosenblatt and Memery Crystal), whilst LionFish and Convex Capital have attractive prospects for FY22. The shares are trading on a current year P/E rating of just 10x, a material discount to peers. We consider this wholly anomalous, given RBG’s trading momentum, clear growth ambitions and attractive dividend yield (6.0% for FY22). Our 160p Target Price suggests 50%+ TSR with the prospect of further outperformance to come, both organic and via accretive M&A. BUY. Positive FY21 year end updateRBG has delivered a strong final quarter, building on the momentum reported in H1. It has been a transformational period for the Group, which has seen the strategically important and accretive Memery Crystal acquisition double legal services revenues, whilst Convex has capitalised on buoyant market conditions. Adjusted EBITDA is now expected to be 10% ahead of previous expectations, which filters through to 14%/13% upgrades to FY21 PBT and EPS. A second interim dividend has been declared (3p per share), reflecting the strong performance and confidence in the outlook. This brings the total dividend in respect of FY21 to 5p per share (ahead of our previous 4.8p forecast). RBG Legal Services – performing well, Memery Crystal largely integratedFollowing the completion of the Memery Crystal acquisition in May 2021, a new legal services corporate entity has been formed – RBG Legal Services Ltd – with two client facing brands of Rosenblatt (for contentious legal services) and Memery Crystal (non-contentious). The business has performed well, the integration of the two firms’ support functions is largely complete, and the benefits are already being seen in terms of collaboration and enhanced client offering. The businesses will move to a new practise management software system in 2022. A sustained improvement in net margins to 29% has already been delivered and this is expected to rise to 35% over the medium term. LionFish and Convex Capital – well positioned at the start of FY22Within litigation finance, the Group expects FY22 to be the year in which returns begin to be generated on LionFish’s litigation investments. Convex Capital, meanwhile, had a very strong FY21, completing 14 deals and generating revenue of £9.4m (2020: 2 deals, revenue of £1.6m). Momentum carried forward from the stellar H1 performance (8 deals, £5m revenue) into H2. At the start of the new year, Convex Capital has a strong pipeline of 22 deals at various stages of completion. Clear valuation anomaly Our 160p TP represents an FY22 P/E rating of 14.5x (based on direct peer group ratings), falling to 13.0x FY23. With continued delivery, we see a strong argument for the shares to trade at a premium to peers, given superior growth and margin credentials. All looks perfectly sensible (inc the TP)
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220926 07:25:01